The mean tissue NO levels in GroupI (control group) was 87.6315 µM/L (standard deviation=1.91631), while the mean tissue NO of Group II (study group) was 172.376µM/L (standard deviation=0.84774.Conclusion: Our results illustrated that the increase in the NO levels in the saliva is positively correlated with the NO level in tissues;hence, salivary NO level can be used as a potential diagnostic biomarker in OSCC.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: The study was conducted to estimate the salivary and tissue nitric oxide (NO) levels in healthy individuals and subjectswith squamous cell carcinoma of the oral cavity.Methods: In this study, the salivary and tissue NO levels were estimated in 20 healthy subjects and 20 patients with oral squamouscell carcinoma (OSCC).Results: The mean salivary NO levels in Group I (control group) was 78.59 µM/L (standard deviation=5.91608), while the meansalivary NO levels of Group II (study group) were 115.6765 µM/L (standard deviation=0.9431).
📊
Key Findings & Data:Objective: The study was conducted to estimate the salivary and tissue nitric oxide (NO) levels in healthy individuals and subjectswith squamous cell carcinoma of the oral cavity.Methods: In this study, the salivary and tissue NO levels were estimated in 20 healthy subjects and 20 patients with oral squamouscell carcinoma (OSCC).Results: The mean salivary NO levels in Group I (control group) was 78.59 µM/L (standard deviation=5.91608), while the meansalivary NO levels of Group II (study group) were 115.6765 µM/L (standard deviation=0.9431).
💡
Conclusion & Impact:The mean tissue NO levels in GroupI (control group) was 87.6315 µM/L (standard deviation=1.91631), while the mean tissue NO of Group II (study group) was 172.376µM/L (standard deviation=0.84774.Conclusion: Our results illustrated that the increase in the NO levels in the saliva is positively correlated with the NO level in tissues;hence, salivary NO level can be used as a potential diagnostic biomarker in OSCC.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Objective: The study was conducted to estimate the salivary and tissue nitric oxide (NO) levels in healthy individuals and subjectswith squamous cell carcinoma of the oral cavity.Methods: In this study, the salivary and tissue NO levels were estimated in 20 healthy subjects and 20 patients with oral squamouscell carcinoma (OSCC).Results: The mean salivary NO levels in Group I (control group) was 78.59 µM/L (standard deviation=5.91608), while the meansalivary NO levels of Group II (study group) were 115.6765 µM/L (standard deviation=0.9431). The mean tissue NO levels in GroupI (control group) was 87.6315 µM/L (standard deviation=1.91631), while the mean tissue NO of Group II (study group) was 172.376µM/L (standard deviation=0.84774.Conclusion: Our results illustrated that the increase in the NO levels in the saliva is positively correlated with the NO level in tissues;hence, salivary NO level can be used as a potential diagnostic biomarker in OSCC.
🔖
Cite This Article
Babu, S. G., Banerjee, B., Ghosh, R., Castelino, R. L. (2022). Estimation of Salivary and Tissue Nitric Oxide Levels in Oral Squamous Cell Carcinoma: A Biochemical Study. European Journal of Therapeutics, Cilt: 27 - Sayı: 1, 26–31. https://ajindex.com/articles/512167
Markopoulos AK. Current aspects on oral squamous cell carcinoma. Open Dent J 2012
[Crossref] 2. Singh MP, Kumar V, Agarwal A, Kumar R, Bhatt MLB, Misra S. Clinico-epidemiological study of oral squamous cell carcinoma: A tertiary care centre study in North India. J Oral Biol and Craniofac Res 2016
[Crossref] 3. Jain V, Dharkar D, Nandin H, Jain SM, Verma S, Shinde PH. Various addiction patterns and duration in head and neck carcinoma: an institutional experience from central India. Int J Health Sci Res 2015
Bray, F, Ren J-S, Masuyer, E, Ferlay, J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013
[Crossref] 5. Parkin DM, Pisani P, Ferlay J. Estimates of worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999
[Crossref] 6. Bhalang K, Suesuwan A, Dhanuthai K, Sannikorn P, Luangjarmekorn L, Swasdison S. The application of acetic acid in the detection of oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008
[Crossref] 7. Mazeau-Woynar V, Cerf N. Survie des patients atteints de cancer en France: état des lieux. Institut National du, Cancer
Yakob M, Fuentes L, Wang MB, Abemayor E, Wong DT. Salivary biomarkers for detection of oral squamous cell carcinoma - current state and recent advances. Curr Oral Health Rep 2014
[Crossref] 9. Berlin NI. Tumor marker in cancer prevention and detection. Cancer 1981
[Crossref] 10. Prasad G, McCullough M. Chemokines and cytokines as salivary biomarkers for the early diagnosis of oral cancer. Int J Dent 2013
813756. [Crossref] 11. Mishra A, Verma M. Cancer biomarkers: are we ready for the prime time? Cancers (Basel) 2010
[Crossref] 12. Taqi SA. Clinical evaluation of total and lipid bound sialic acid levels in oral precancer and oral cancer. Ind J Med Paed Oncol 2012
[Crossref] 13. Mocellin S, Bronte V, Nitti D. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med Res Rev 2007
[Crossref] 14. Bentz BG, Simmons RL, Haines GK, Radosevich JA. The yin and yang of nitric oxide: reflections on the physiology and pathophysiology of NO. Head Neck 2000
[Crossref] 15. Ying L, Hofseth LJ. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res 2007